8CG-56080-38519
2 vaccinations
2 coded responses
15 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 386 / MS
- Registered
- 2021-01-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-01
Registered in v-safe
-
2021-01-01
Dose 1 — Moderna
- 2021-01-01
- 2021-01-02
-
2021-01-03
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-04
- 2021-01-05
- 2021-01-06
- 2021-01-08
- 2021-01-15
-
2021-01-22
Survey response — day 21, dose 1MedDRA: Fatigue, Insomnia, Pregnancy — Feeling: Poor · Be unable to work, Be unable to do your normal daily activitiesFree text: Extreme fatigue, but its possible its related to pregnancy and not getting enough sleepMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-22
Report sent to call center — day 21, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-29
Dose 2 — Moderna
- 2021-02-26
- 2021-03-07
- 2021-03-12
-
2021-04-30
Survey response — 3 months, dose 2MedDRA: Gestational diabetes, Gestational hypertension — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Gestational hypertension and gestational diabetesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-30
Report sent to call center — 3 months, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-04
- 2021-07-30
- 2022-01-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-01 | Moderna | |
| 2 | 2021-01-29 | Moderna |
Call center
2 call center cases
1 unsuccessful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 2 — day 21, dose 1
Symptoms: Extreme fatigue, but its possible its related to pregnancy and not getting enough sleep
Release 8 — 3 months, dose 2
Symptoms: Gestational hypertension and gestational diabetes
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Gestational diabetes | ✓ | ✓ | ✓ |
| SD | Gestational hypertension | ✓ | ✓ | ✓ |
| SD | Insomnia | ✓ | ✓ | ✓ |
| SD | Pregnancy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release